Immunotherapy and targeted therapy combinations in metastatic breast cancer

FJ Esteva, VM Hubbard-Lucey, J Tang… - The lancet oncology, 2019 - thelancet.com
Immunotherapy is emerging as a new treatment modality in breast cancer. After long-
standing use of endocrine therapy and targeted biological therapy, improved understanding …
被引用次数：430 相关文章

[引用][C] Immunotherapy and targeted therapy combinations in metastatic breast cancer

FJ Esteva, VM Hubbard-Lucey, J Tang, L Pusztai - The Lancet Oncology, 2019 - cir.nii.ac.jp
Immunotherapy and targeted therapy combinations in metastatic breast cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Immunotherapy and targeted therapy combinations in metastatic breast cancer.

FJ Esteva, VM Hubbard-Lucey, J Tang… - The Lancet …, 2019 - europepmc.org
Immunotherapy is emerging as a new treatment modality in breast cancer. After long-
standing use of endocrine therapy and targeted biological therapy, improved understanding …

Immunotherapy and targeted therapy combinations in metastatic breast cancer

FJ Esteva, VM Hubbard-Lucey, J Tang… - The Lancet …, 2019 - pubmed.ncbi.nlm.nih.gov
Immunotherapy is emerging as a new treatment modality in breast cancer. After long-
standing use of endocrine therapy and targeted biological therapy, improved understanding …

Immunotherapy and targeted therapy combinations in metastatic breast cancer

FJ Esteva, VM Hubbard-Lucey, J Tang, L Pusztai - The Lancet Oncology, 2019 - Elsevier
Immunotherapy is emerging as a new treatment modality in breast cancer. After long-
standing use of endocrine therapy and targeted biological therapy, improved understanding …